Difference between revisions of "Soft tissue lesions"
(→Aggressive angiomyxoma: more) |
|||
(74 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
'''Soft tissue lesions''' strike fear in many pathologists as they are uncommon and may be difficult to diagnose. | '''Soft tissue lesions''' strike fear in many pathologists as they are uncommon and may be difficult to diagnose. Malignant soft tissue lesions, i.e. [[cancer|cancerous]] soft tissue lesions, are usually '''sarcomas'''. Sarcomas are malignancies derived from mesenchymal tissue. | ||
=Introduction= | =Introduction= | ||
Line 27: | Line 27: | ||
*Once upon a time almost everything was called ''malignant fibrous histiocytoma''; thus, it is listed as a common entity in some publications. | *Once upon a time almost everything was called ''malignant fibrous histiocytoma''; thus, it is listed as a common entity in some publications. | ||
Most common:<ref name=pmid17976362>{{cite journal |author=Skubitz KM, D'Adamo DR |title=Sarcoma |journal=Mayo Clin. Proc. |volume=82 |issue=11 |pages=1409–32 |year=2007 |month=November |pmid=17976362 |doi= |url= http://www.mayoclinicproceedings.com/content/82/11/1409.long}}</ref> | |||
*Liposarcoma. | *Liposarcoma. | ||
*Leiomyosarcoma. | *Leiomyosarcoma. | ||
Line 44: | Line 44: | ||
==Morphohistologic patterns== | ==Morphohistologic patterns== | ||
{{Main| | {{Main|Morphologic patterns}} | ||
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | {| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | ||
! Name | ! Name | ||
Line 50: | Line 50: | ||
! DDx | ! DDx | ||
! Image(s) | ! Image(s) | ||
|- | |- | ||
| Storiform, [[AKA]] patternless pattern<ref name=pmid9704618>{{cite journal |author=Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL |title=The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining |journal=Am. J. Clin. Pathol. |volume=110 |issue=2 |pages=191–9 |year=1998 |month=August |pmid=9704618 |doi= |url=}}</ref> | | Storiform, [[AKA]] patternless pattern<ref name=pmid9704618>{{cite journal |author=Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL |title=The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining |journal=Am. J. Clin. Pathol. |volume=110 |issue=2 |pages=191–9 |year=1998 |month=August |pmid=9704618 |doi= |url=}}</ref> | ||
| whorled, cartwheel-like arrangement | | whorled, cartwheel-like arrangement | ||
| [[pleomorphic undifferentiated sarcoma]], [[solitary fibrous tumour]], [[dermatofibrosarcoma protuberans]], [[dermatofibroma]]<ref name=pmid224569>{{cite journal |author=Meister P, Höhne N, Konrad E, Eder M |title=Fibrous histiocytoma: an analysis of the storiform pattern |journal=Virchows Arch A Pathol Anat Histol |volume=383 |issue=1 |pages=31–41 |year=1979 |month=July |pmid=224569 |doi= |url=}}</ref> | | [[pleomorphic undifferentiated sarcoma]], [[solitary fibrous tumour]], [[dermatofibrosarcoma protuberans]], [[dermatofibroma]]<ref name=pmid224569>{{cite journal |author=Meister P, Höhne N, Konrad E, Eder M |title=Fibrous histiocytoma: an analysis of the storiform pattern |journal=Virchows Arch A Pathol Anat Histol |volume=383 |issue=1 |pages=31–41 |year=1979 |month=July |pmid=224569 |doi= |url=}}</ref> | ||
| [ | | [[Image:Storiform_pattern_-_intermed_mag.jpg |thumb|center|150px| Patternless pattern. (WC)]] | ||
|- | |- | ||
| Herring bone | | Herring bone | ||
| like herring bone (technique) for climbing a hill in cross country skiing; books on a shelf, where they have partially fallen over -- on the one shelf to the left and the one below to the right | | like herring bone (technique) for climbing a hill in cross country skiing; books on a shelf, where they have partially fallen over -- on the one shelf to the left and the one below to the right | ||
| [[fibrosarcoma]], [[synovial sarcoma]], [[MPNST]] | | [[fibrosarcoma]], [[synovial sarcoma]], [[MPNST]] | ||
| [ | | [[Image:Malignant_peripheral_nerve_sheath_tumour_-_intermed_mag.jpg |thumb|center|150px |Herring bone. (WC)]] | ||
|- | |- | ||
| | | Fascicular | ||
| the long axis of the (spindle) cells are perpendicular to one another in adjacent bundles of cells | | the long axis of the (spindle) cells are perpendicular to one another in adjacent bundles of cells | ||
| [[leiomyoma]], [[leiomyosarcoma]] | | [[leiomyoma]], [[leiomyosarcoma]] | ||
| [ | | [[Image:Cutaneous_leiomyosarcoma_-_high_mag.jpg |thumb|center|150px| Fascicular pattern. (WC)]] | ||
|- | |- | ||
| Biphasic | | Biphasic | ||
| nests of cells and stroma | | nests of cells and stroma | ||
| [[synovial sarcoma]], [[DSRCT]], [[alveolar RMS]] | | [[synovial sarcoma]], [[DSRCT]], [[alveolar RMS]] | ||
| [ | | [[Image:Desmoplastic_small_round_cell_tumour_-_high_mag.jpg|thumb|center|150px| DSRCT. (WC)]] | ||
|- <!-- | |- <!-- | ||
| name ? | | name ? | ||
| description ? | | description ? | ||
| DDx ? | | DDx ? | ||
| image | | image ? --> | ||
|} | |} | ||
Line 92: | Line 86: | ||
===French system=== | ===French system=== | ||
Overview:<ref name=pmid8996162/><ref name=uscap_stp>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 12 April 2011.</ref> | *Formally known as the grading system from the ''French Federation of Cancer Centres Sarcoma Group'' (FNCLCC). | ||
====Overview==== | |||
Components - overview:<ref name=pmid8996162/><ref name=uscap_stp>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 12 April 2011.</ref> | |||
#Differentiation (score 1-3). | #Differentiation (score 1-3). | ||
#*De facto, this is mostly the ''histologic type''. | #*De facto, this is mostly the ''histologic type''. | ||
Line 153: | Line 150: | ||
*Cellularity (cells/matrix) > 50%. | *Cellularity (cells/matrix) > 50%. | ||
*Necrosis >15% - microscopic (without targeting necrosis grossly) ''or'' grossly. | *Necrosis >15% - microscopic (without targeting necrosis grossly) ''or'' grossly. | ||
==Stage== | |||
{{Main|Cancer staging systems}} | |||
===Lymph node metastases in sarcomas=== | |||
{{Main|Lymph node metastasis}} | |||
*[[Lymph node]] (LN) spread is uncommon in sarcomas; [[lymph node metastases]] are seen in <3% of cases.<ref name=pmid8424704>{{Cite journal | last1 = Fong | first1 = Y. | last2 = Coit | first2 = DG. | last3 = Woodruff | first3 = JM. | last4 = Brennan | first4 = MF. | title = Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. | journal = Ann Surg | volume = 217 | issue = 1 | pages = 72-7 | month = Jan | year = 1993 | doi = | PMID = 8424704 | PMC = 1242736}}</ref> | |||
**Many sarcomas are reported in LNs. | |||
***According to the [[CAP checklist]] for soft tissue<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf]. Accessed on: 28 March 2012.</ref> the most common are: [[epithelioid sarcoma]] and [[clear cell sarcoma]]. | |||
***According to Fong ''et al.''<ref name=pmid8424704/> the most commonly is: angiosarcoma. | |||
Sarcomas more likely to be found in the lymph nodes - mnemonic ''RACE For MS'':<ref>URL: [http://www.aippg.net/forum/f21/surgery-mnemonics-79897/ http://www.aippg.net/forum/f21/surgery-mnemonics-79897/]. Accessed on: 23 March 2012.</ref> | |||
*[[rhabdomyosarcoma|'''R'''habdomyosarcoma]] | |||
*[[Angiosarcoma|'''A'''ngiosarcoma]]. | |||
*[[clear cell sarcoma|'''C'''lear cell sarcoma]]. | |||
*[[epithelioid sarcoma|'''E'''pitheliod sarcoma]]. | |||
*[[fibrosarcoma|'''F'''ibrosarcoma]]. | |||
*[[pleomorphic undifferentiated sarcoma|'''M'''alignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma)]]. | |||
*[[synovial sarcoma|'''S'''ynovial cell sarcoma]]. | |||
==DDx by history/site== | ==DDx by history/site== | ||
Line 196: | Line 211: | ||
=Fibrohistiocytic tumours= | =Fibrohistiocytic tumours= | ||
''Fibrohistiocytic'' refers (only) to the histomorphologic appearance and therefore may be written in quotation marks; these tumours are not derived from histiocytes (or tissue macrophages), as the name implies.<ref name=pmid20055912>{{Cite journal | last1 = Luzar | first1 = B. | last2 = Calonje | first2 = E. | title = Cutaneous fibrohistiocytic tumours - an update. | journal = Histopathology | volume = 56 | issue = 1 | pages = 148-65 | month = Jan | year = 2010 | doi = 10.1111/j.1365-2559.2009.03447.x | PMID = 20055912 }}</ref> | |||
==Pleomorphic undifferentiated sarcoma== | ==Pleomorphic undifferentiated sarcoma== | ||
*Abbreviated ''PUS''. | *Abbreviated ''PUS''. | ||
*[[AKA]] ''Undifferentiated pleomorphic sarcoma'', abbreviated ''UPS''. | *[[AKA]] ''Undifferentiated pleomorphic sarcoma'', abbreviated ''UPS''. | ||
*Previously known as ''malignant fibrous histiocytoma'', abbreviated ''MFH''.<ref>URL: [http://sarcomahelp.org/learning_center/mfh.html http://sarcomahelp.org/learning_center/mfh.html]. Accessed on: 8 April 2011.</ref> | *Previously known as ''malignant fibrous histiocytoma'', abbreviated ''MFH''.<ref>URL: [http://sarcomahelp.org/learning_center/mfh.html http://sarcomahelp.org/learning_center/mfh.html]. Accessed on: 8 April 2011.</ref> | ||
{{Main|Pleomorphic undifferentiated sarcoma}} | |||
=Fibroblastic/myofibroblastic tumours= | =Fibroblastic/myofibroblastic tumours= | ||
Line 287: | Line 271: | ||
=Tumours of uncertain differentiation= | =Tumours of uncertain differentiation= | ||
==Angiomatoid fibrous histiocytoma== | ==Angiomatoid fibrous histiocytoma== | ||
{{Main|Angiomatoid fibrous histiocytoma}} | |||
==Aggressive angiomyxoma== | ==Aggressive angiomyxoma== | ||
*[[AKA]] deep aggressive angiomyxoma. | *[[AKA]] deep aggressive angiomyxoma. | ||
{{Main|Aggressive angiomyxoma}} | |||
==Angiomyofibroblastoma== | ==Angiomyofibroblastoma== | ||
{{Main|Angiomyofibroblastoma}} | |||
==Extrarenal malignant rhabdoid tumour== | ==Extrarenal malignant rhabdoid tumour== | ||
*Essentially identical to ''[[renal malignant rhabdoid tumour]]''.<ref name=Ref_WMSP627>{{Ref WMSP|627}}</ref> | *Essentially identical to ''[[renal malignant rhabdoid tumour]]''.<ref name=Ref_WMSP627>{{Ref WMSP|627}}</ref> | ||
{{Main|Extrarenal malignant rhabdoid tumour}} | |||
==Ewing sarcoma/PNET== | ==Ewing sarcoma/PNET== | ||
Line 396: | Line 289: | ||
==Epithelioid sarcoma== | ==Epithelioid sarcoma== | ||
:Sarcomas with an epithelioid morphology are covered in ''[[epithelioid sarcomas]]''. | |||
{{Main|Epithelioid sarcoma}} | |||
==Alveolar soft part sarcoma== | ==Alveolar soft part sarcoma== | ||
{{Main|Alveolar soft part sarcoma}} | |||
==Desmoplastic small round cell tumour== | ==Desmoplastic small round cell tumour== | ||
{{Main|Desmoplastic small round cell tumour}} | |||
==Clear cell sarcoma== | ==Clear cell sarcoma== | ||
{{Main|Clear cell sarcoma}} | |||
==Synovial sarcoma== | ==Synovial sarcoma== | ||
{{Main|Synovial sarcoma}} | |||
=Other= | =Other= | ||
==Granulocytic sarcoma== | ==Granulocytic sarcoma== | ||
*Common alternate terms: myeloid sarcoma, chloroma. | *Common alternate terms: extramedullary leukemia,<ref name=pmid21795742>{{Cite journal | last1 = Bakst | first1 = RL. | last2 = Tallman | first2 = MS. | last3 = Douer | first3 = D. | last4 = Yahalom | first4 = J. | title = How I treat extramedullary acute myeloid leukemia. | journal = Blood | volume = 118 | issue = 14 | pages = 3785-93 | month = Oct | year = 2011 | doi = 10.1182/blood-2011-04-347229 | PMID = 21795742 }}</ref> myeloid sarcoma, chloroma. | ||
*Other terms:<ref name=pmid21556238>{{Cite journal | last1 = Eom | first1 = KS. | last2 = Kim | first2 = TY. | title = Intraparenchymal myeloid sarcoma and subsequent spinal myeloid sarcoma for acute myeloblastic leukemia. | journal = J Korean Neurosurg Soc | volume = 49 | issue = 3 | pages = 171-4 | month = Mar | year = 2011 | doi = 10.3340/jkns.2011.49.3.171 | PMID = 21556238 | PMC = 3085814 | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085814/ }}</ref> myeloblastoma, chloromyeloma, chloromyelosarcoma, granulocytic leukosarcoma, or myelosarcoma. | *Other terms:<ref name=pmid21556238>{{Cite journal | last1 = Eom | first1 = KS. | last2 = Kim | first2 = TY. | title = Intraparenchymal myeloid sarcoma and subsequent spinal myeloid sarcoma for acute myeloblastic leukemia. | journal = J Korean Neurosurg Soc | volume = 49 | issue = 3 | pages = 171-4 | month = Mar | year = 2011 | doi = 10.3340/jkns.2011.49.3.171 | PMID = 21556238 | PMC = 3085814 | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085814/ }}</ref> myeloblastoma, chloromyeloma, chloromyelosarcoma, granulocytic leukosarcoma, or myelosarcoma. | ||
{{Main|Granulocytic sarcoma}} | |||
=See also= | =See also= |
Latest revision as of 12:50, 3 November 2015
Soft tissue lesions strike fear in many pathologists as they are uncommon and may be difficult to diagnose. Malignant soft tissue lesions, i.e. cancerous soft tissue lesions, are usually sarcomas. Sarcomas are malignancies derived from mesenchymal tissue.
Introduction
WHO classification of soft tissue lesions/tumours
Morphologic grouping
These include:[1]
- Adipocytic tumours.
- Fibroblastic/myofibroblastic tumours.
- "Fibrohistiocytic" tumours.
- Smooth muscle tumours.
- Skeletal muscle tumours.
- Vascular tumours.
- Perivascular (pericytic) tumours.
- Chondro-osseous tumours.
- Tumours of uncertain differentiation.
Biologic potential grouping
These include:[2]
- Benign.
- Intermediate (locally aggressive).
- Intermediate (rarely metastasizing).
- Malignant.
Prevalence
- All sarcomas are rare buggers.
- As the classification has been changing over the past years (with more subtypes being recognized/identified) numbers are variable from study-to-study.
- Once upon a time almost everything was called malignant fibrous histiocytoma; thus, it is listed as a common entity in some publications.
Most common:[3]
- Liposarcoma.
- Leiomyosarcoma.
Molecular testing
- Molecular testing plays an important role in soft tissue pathology.
- It is generally seen as an adjunct test that:[4]
- Often is used to confirm the histomorphologic impression/quality control.
- Frequently has some prognostic significance.
- May directly affect treatment.
Translocations
- Many tumours in soft tissue pathology are diagnosed inconjunction with the finding of chromosomal translocations.
Morphohistologic patterns
Name | Description | DDx | Image(s) |
---|---|---|---|
Storiform, AKA patternless pattern[5] | whorled, cartwheel-like arrangement | pleomorphic undifferentiated sarcoma, solitary fibrous tumour, dermatofibrosarcoma protuberans, dermatofibroma[6] | |
Herring bone | like herring bone (technique) for climbing a hill in cross country skiing; books on a shelf, where they have partially fallen over -- on the one shelf to the left and the one below to the right | fibrosarcoma, synovial sarcoma, MPNST | |
Fascicular | the long axis of the (spindle) cells are perpendicular to one another in adjacent bundles of cells | leiomyoma, leiomyosarcoma | |
Biphasic | nests of cells and stroma | synovial sarcoma, DSRCT, alveolar RMS |
Notes:
- Memory device: herring bone DDx MSF = MPNST, Synovial sarcoma, Fibrosarcoma.
Grading
- Several systems exist.
- The US-CAP advocates the use of the French system over the NCI system.
- The French system is a better predictor metastases and mortality.[7]
French system
- Formally known as the grading system from the French Federation of Cancer Centres Sarcoma Group (FNCLCC).
Overview
- Differentiation (score 1-3).
- De facto, this is mostly the histologic type.
- Mitotic rate (score 1-3).
- Necrosis (score 0-2)
Obtaining a score:
- Add all the points from the three components.
Scoring:
- Grade 1 = 2-3.
- Grade 2 = 4-5.
- Grade 3 = 6-8.
Differentiation
- Standardized for histologic types.
- Most tumours = 3/3.
Exceptions:[8]
- Well-differentiated liposarcoma = 1.
- Myxoid liposarcoma = 2.
- Conventional liposarcoma = 2.
- Fibrosarcoma = 2.
- Myxofibrosarcoma =2.
A group of tumours is not graded:[8]
- MPNST.
- Rhabdomyosarcoma.
- Alveolar soft part sarcoma.
- Clear cell sarcoma.
- Extraskeletal myxoid chondrosarcoma.
Mitotic rate
- 0-9 mitoses/10 HPF.
- 10-19 mitoses/10 HPF.
- >=20 mitoses/10 HPF.
Notes:
- 1 HPF = 0.1734 mm^2.
- Most resident microscopes have a field of view = 0.2376 mm^2.
- Thus, ~7.3 HPFs on a resident microscope corresponds to 10 US-CAP HPFs.
- Most resident microscopes have a field of view = 0.2376 mm^2.
Necrosis
- None = score 0.
- <=50% of tumour = score 1.
- >50% of tumour = score 2.
System used by some at MSH
Some pathologists at MSH use the system advocated by Costa et al..[9]
Scoring
- Grade 1 = 1 point.
- Grade 2 = 2 points.
- Grade 3 = 3-4 points.
Components
Points for each of the following:
- Mitotic activity >= 6 / 10 HPF @ 40X - definition suffers from HPFitis.
- Pleomorphism present.
- Cellularity (cells/matrix) > 50%.
- Necrosis >15% - microscopic (without targeting necrosis grossly) or grossly.
Stage
Lymph node metastases in sarcomas
- Lymph node (LN) spread is uncommon in sarcomas; lymph node metastases are seen in <3% of cases.[10]
- Many sarcomas are reported in LNs.
- According to the CAP checklist for soft tissue[11] the most common are: epithelioid sarcoma and clear cell sarcoma.
- According to Fong et al.[10] the most commonly is: angiosarcoma.
- Many sarcomas are reported in LNs.
Sarcomas more likely to be found in the lymph nodes - mnemonic RACE For MS:[12]
- Rhabdomyosarcoma
- Angiosarcoma.
- Clear cell sarcoma.
- Epitheliod sarcoma.
- Fibrosarcoma.
- Malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma).
- Synovial cell sarcoma.
DDx by history/site
Retroperiteum
Note: Synovial sarcoma and fibrosarcoma are very rare in the retroperitoneum.
Young person - extremity sarcoma
Gross characteristics
- Usually non-specific.
- Most sarcomas have a pushing border.
- If there is an infiltrative border think: (1) fibromatosis, (2) carcinoma.
Adipocytic tumours
This category includes:
- Lipoma.
- Liposarcoma.
- Hibernoma.
Smooth muscle tumours
IHC markers: desmin, SMA, H-caldemsin (most specific).
Leiomyosarcoma
Microscopic
Features (summary):
- Fasicular cellular spindle cell lesion with:
- Nuclear atypia.
- Necrosis.
- High mitotic rate.
Fibrohistiocytic tumours
Fibrohistiocytic refers (only) to the histomorphologic appearance and therefore may be written in quotation marks; these tumours are not derived from histiocytes (or tissue macrophages), as the name implies.[13]
Pleomorphic undifferentiated sarcoma
- Abbreviated PUS.
- AKA Undifferentiated pleomorphic sarcoma, abbreviated UPS.
- Previously known as malignant fibrous histiocytoma, abbreviated MFH.[14]
Fibroblastic/myofibroblastic tumours
This is a very large and important group of soft tissue lesions. It is covered in a separate article.
The grouping includes:
- Inflammatory myofibroblastic tumour.
- Nodular fasciitis.
- Desmoid-type fibromatosis (Desmoid tumour).
- Proliferative fasciitis.
- Solitary fibrous tumour (Hemangiopericytoma).
- Desmoplastic fibroblastoma.
- Low-grade fibromyxoid sarcoma.
- Others.
Perivascular tumours
This grouping includes only two:[15]
- Glomus tumour - both benign and malignant.
- Myopericytoma.
Vascular lesions
Vascular lesions are "too red"; they have too many RBCs.
They include:
Skeletal muscle tumours
Rhabdomyoma
Rhabdomyosarcoma
- Abbreviated RMS.
Comes it two main flavours:
- Alveolar rhabdomyosarcoma.
- Embryonal rhabdomyosarcoma.
The histology may be that of a small round cell tumour.
Chondro-osseous tumours
This grouping includes tumours derived from cartilage and bone.
Tumours of uncertain differentiation
Angiomatoid fibrous histiocytoma
Aggressive angiomyxoma
- AKA deep aggressive angiomyxoma.
Angiomyofibroblastoma
Extrarenal malignant rhabdoid tumour
- Essentially identical to renal malignant rhabdoid tumour.[16]
Ewing sarcoma/PNET
- A small round blue cell tumour that may be seen in bone. It is discussed in the context of bone tumours.
Epithelioid sarcoma
- Sarcomas with an epithelioid morphology are covered in epithelioid sarcomas.
Alveolar soft part sarcoma
Desmoplastic small round cell tumour
Clear cell sarcoma
Synovial sarcoma
Other
Granulocytic sarcoma
- Common alternate terms: extramedullary leukemia,[17] myeloid sarcoma, chloroma.
- Other terms:[18] myeloblastoma, chloromyeloma, chloromyelosarcoma, granulocytic leukosarcoma, or myelosarcoma.
See also
- Bone.
- Dermatopathology.
- Hematopathology.
- Spindle cell lesion.
- Neurofibromatosis.
- Small round cell tumours.
References
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 601-3. ISBN 978-0781765275.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 598-604. ISBN 978-0781765275.
- ↑ Skubitz KM, D'Adamo DR (November 2007). "Sarcoma". Mayo Clin. Proc. 82 (11): 1409–32. PMID 17976362. http://www.mayoclinicproceedings.com/content/82/11/1409.long.
- ↑ Fletcher CD, Fletcher JA, Dal Cin P, Ladanyi M, Woodruff JM (July 2001). "Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?". Histopathology 39 (1): 100–3. PMID 11454050.
- ↑ Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL (August 1998). "The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining". Am. J. Clin. Pathol. 110 (2): 191–9. PMID 9704618.
- ↑ Meister P, Höhne N, Konrad E, Eder M (July 1979). "Fibrous histiocytoma: an analysis of the storiform pattern". Virchows Arch A Pathol Anat Histol 383 (1): 31–41. PMID 224569.
- ↑ 7.0 7.1 Guillou L, Coindre JM, Bonichon F, et al. (January 1997). "Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma". J. Clin. Oncol. 15 (1): 350–62. PMID 8996162.
- ↑ 8.0 8.1 8.2 URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf. Accessed on: 12 April 2011.
- ↑ Costa J, Wesley RA, Glatstein E, Rosenberg SA (February 1984). "The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases". Cancer 53 (3): 530–41. PMID 6692258.
- ↑ 10.0 10.1 Fong, Y.; Coit, DG.; Woodruff, JM.; Brennan, MF. (Jan 1993). "Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients.". Ann Surg 217 (1): 72-7. PMC 1242736. PMID 8424704. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242736/.
- ↑ URL: http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/SoftTissue_11protocol.pdf. Accessed on: 28 March 2012.
- ↑ URL: http://www.aippg.net/forum/f21/surgery-mnemonics-79897/. Accessed on: 23 March 2012.
- ↑ Luzar, B.; Calonje, E. (Jan 2010). "Cutaneous fibrohistiocytic tumours - an update.". Histopathology 56 (1): 148-65. doi:10.1111/j.1365-2559.2009.03447.x. PMID 20055912.
- ↑ URL: http://sarcomahelp.org/learning_center/mfh.html. Accessed on: 8 April 2011.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 602. ISBN 978-0781765275.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 627. ISBN 978-0781765275.
- ↑ Bakst, RL.; Tallman, MS.; Douer, D.; Yahalom, J. (Oct 2011). "How I treat extramedullary acute myeloid leukemia.". Blood 118 (14): 3785-93. doi:10.1182/blood-2011-04-347229. PMID 21795742.
- ↑ Eom, KS.; Kim, TY. (Mar 2011). "Intraparenchymal myeloid sarcoma and subsequent spinal myeloid sarcoma for acute myeloblastic leukemia.". J Korean Neurosurg Soc 49 (3): 171-4. doi:10.3340/jkns.2011.49.3.171. PMC 3085814. PMID 21556238. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085814/.